Related Experiment Video
Updated: May 12, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
STAT1 negatively regulates hepatocellular carcinoma cell proliferation
Guofu Chen1, Haihe Wang, Shuli Xie
1Department of General Surgery, the First Hospital of Jilin University, Changchun, Jilin 130021, PR China. guofuch163@163.com
Signal transducer and activator of transcription 1 (STAT1) is downregulated in hepatocellular carcinoma (HCC). STAT1 inhibits HCC cell proliferation and promotes apoptosis, suggesting its potential as a therapeutic target for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Signal transducer and activator of transcription 1 (STAT1) is crucial for regulating cell proliferation and survival.
- The role of STAT1 in the development and progression of human hepatocellular carcinoma (HCC) requires further investigation.
Purpose of the Study:
- To investigate the expression levels of STAT1 in HCC tissues.
- To determine the functional role of STAT1 in HCC cell proliferation, apoptosis, and relevant molecular pathways.
Main Methods:
- Immunohistochemistry was used to assess STAT1 expression in 36 HCC and 12 non-HCC liver tissues.
- MTT and flow cytometry assays were employed to evaluate the effects of STAT1 modulation on HCC cell proliferation and apoptosis.
- Quantitative PCR and western blot assays were utilized to analyze the expression of p53 and cyclin E following STAT1 manipulation.
Main Results:
- STAT1 expression was significantly lower in HCC tissues compared to non-HCC tissues and inversely correlated with HCC grade and serological markers.
- STAT1 overexpression inhibited HepG2 cell proliferation and induced apoptosis, upregulating p53 and STAT1 phosphorylation while downregulating cyclin E.
- STAT1 knockdown promoted HepG2 cell proliferation and inhibited apoptosis, downregulating p53 and upregulating cyclin E.
Conclusions:
- STAT1 plays an inhibitory role in HCC development and progression.
- STAT1 may exert its tumor-suppressive effects by modulating p53-related cell cycling and apoptosis pathways in HCC.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
